PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS

被引：14
|
作者：
Dumas, E. O. [1 ]
Lawal, A. [1 ]
Menon, R. M. [1 ]
Podsadecki, T. [1 ]
Awni, W. [1 ]
Dutta, S. [1 ]
Williams, L. [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61206-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1204
引用
收藏
页码：S475 / S476
页数：2
相关论文
共 50 条
  • [1] Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A
    DeGoey, David A.
    Randolph, John T.
    Liu, Dachun
    Pratt, John
    Hutchins, Charles
    Donner, Pamela
    Krueger, A. Chris
    Matulenko, Mark
    Patel, Sachin
    Motter, Christopher E.
    Nelson, Lissa
    Keddy, Ryan
    Tufano, Michael
    Caspi, Daniel D.
    Krishnan, Preethi
    Mistry, Neeta
    Koev, Gennadiy
    Reisch, Thomas J.
    Mondal, Rubina
    Pilot-Matias, Tami
    Gao, Yi
    Beno, David W. A.
    Maring, Clarence J.
    Molla, Akhter
    Dumas, Emily
    Campbell, Andrew
    Williams, Laura
    Collins, Christine
    Wagner, Rolf
    Kati, Warren M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 2047 - 2057
  • [2] PHARMACOKINETICS, TOLERABILITY AND EFFECT OF FOOD ON HCV POLYMERASE INHIBITOR ABT-333 FOLLOWING SINGLE ASCENDING DOSES IN HEALTHY ADULT VOLUNTEERS
    Menon, R.
    Cohen, D.
    Nada, A.
    Dumas, E. Olson
    Chiu, Y. -L.
    Podsadecki, T.
    Awni, W.
    Bernstein, B.
    Klein, C.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S347 - S348
  • [3] Safety and Pharmacokinetics of Single and Multiple Oral Doses of MK-8742, an HCV NS5A Inhibitor, in Healthy Subjects
    Mangin, Eric
    Yeh, Wendy W.
    Caro, Luzelena
    Lipardi, Concetta
    Mitselos, Anna
    Fraser, Iain P.
    Jumes, Patricia
    Huang, Xiaobi
    Dreyer, Daniel
    Van Bortel, Lucas M.
    Butterton, Joan R.
    HEPATOLOGY, 2013, 58 : 444A - 444A
  • [4] Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C
    Stirnimann, Guido
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2609 - 2622
  • [5] PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR ABT-072 FOLLOWING SINGLE AND MULTIPLE DOSING IN HEALTHY ADULT VOLUNTEERS
    Dumas, E.
    Awni, W.
    Cohen, D.
    Bernstein, B.
    Nada, A.
    Chiu, Y. L.
    Klein, C.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S291 - S291
  • [6] Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers
    Kunka, RL
    Hussey, EK
    Shaw, S
    Warner, P
    Aubert, B
    Richard, I
    Fowler, PA
    Pakes, GE
    CEPHALALGIA, 1997, 17 (04) : 532 - 540
  • [7] Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
    Rolan, Paul
    Gibbons, Jacqueline A.
    He, Lin
    Chang, Eppie
    Jones, Drew
    Gross, Matthew I.
    Davidson, Jennifer Bahr
    Sanftner, Laura M.
    Johnson, Kirk W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (06) : 792 - 801
  • [8] Pharmacokinetics, Safety, and Tolerability of EDP-239, a Novel Hepatitis C NS5A inhibitor, in Healthy Volunteers
    Jiang, Lijuan
    Jiang, Xuemin
    Dole, Kiran
    Caliri, Kimberley
    Tack, Kenneth
    Colvin, Richard
    Or, Yat Sun
    HEPATOLOGY, 2015, 62 : 1307A - 1307A
  • [9] PHARMACOKINETICS, TOLERABILITY AND SAFETY OF ABT-530 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY SUBJECTS.
    Lin, C.
    Dutta, S.
    Clifton, J., II
    Asatryan, A.
    Campbell, A.
    Liu, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S69 - S69
  • [10] Pharmacokinetics, Safety and Tolerability of Cyclosporine or Tacrolimus Following Coadministration of ABT-450/r, ABT-267 and ABT-333 in Healthy Subjects.
    Badri, P.
    Cohen, D.
    Ding, B.
    Podsadecki, T.
    Bernstein, B.
    Awni, W.
    Dutta, S.
    Menon, R.
    TRANSPLANTATION, 2014, 98 : 736 - 736
12345